The drugmaker is already carrying out a second phase 3 trial of Fasenra in CRSwNP – called ORCHID – which isn't due to generate results until September 2023, according the listing for the ...

A patient-reported outcome (PRO) measure consisting of verbal response scales to assess symptoms of chronic rhinosinusitis with nasal polyps (CRSwNP) was well understood by patients and focused on the ...

Welcome to Fierce Pharma's regulatory tracker for the first half of 2025. On this page, we're recording the regulatory progress of in-market products, including expansions into key geographies and ...

Abstract: Chronic rhinosinusitis with nasal polyps (CRSwNP), as one of the most common chronic nasal inflammations, has been a major research focus in the field of rhinology due to its complex and ...

Mepolizumab is under clinical development by GSK and currently in Phase III for Chronic Obstructive Pulmonary Disease (COPD). According to GlobalData, Phase III drugs for Chronic Obstructive Pulmonary ...

Jan. 10, 2025 — More than half of 23-year-olds in a European study show restrictive, emotional or uncontrolled eating behaviors, according to new research. ... Climate Fee on Food Could ...

A$AP Rocky trial: Rapper accused of firing gun at former friend On the first day of A$AP Rocky 's trial, jurors saw surveillance videos that a prosecutor argued make ...

Jan. 23, 2025 — Researchers have uncovered which genes on the Y chromosome regulate the development of sperm and impact fertility in male mice. This research could help us understand why some ...

A Wall St. street sign is seen near the New York Stock Exchange (NYSE) in New York City, U.S., September 17, 2019. REUTERS/Brendan McDermid/File Photo The tepid reception to Venture Global's ...

Weeks after the worst of the deadly fires tore through Los Angeles suburbs, families are grappling with the reality that toxic ash from burned cars and homes could be a health issue for awhile ...